Brain scan surveillance in HER2-positive metastatic breast cancer
Part of Cancer, Skin clinical trials.
This study tests whether regular brain scans (surveillance) help spot brain metastases early in people with HER2-positive breast cancer that has spread to other parts of the body. Participation involves being randomly assigned to either routine brain scans or no extra scans to see which approach is better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have HER2-positive breast cancer that has spread to distant organs (metastatic)
- You have cancer in at least one internal organ (like the lungs, liver, or similar)
- You are currently receiving treatment that targets HER2
- You have never had cancer spread to the brain or symptoms suggesting it
- You can undergo an MRI scan (no metal implants or severe claustrophobia)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether regular brain MRI scans can help detect brain metastases early in patients with stage IV breast cancer who do not yet have any known brain metastases. The goal is to see if early detection improves outcomes.
This trial checks the brain using MRI in people with breast cancer that has spread outside the breast or can’t be fully removed. The goal is to screen for brain involvement and see how MRI findings fit with treatment timing, when it’s safe to do so.
This trial uses an MRI scan to look for early signs of breast cancer spreading to the brain in people with certain aggressive breast cancer types (triple-negative or HER2-positive) that are stage IIb or III. The goal is to find and treat brain metastases earlier, before they cause symptoms.
This study looks at factors that affect survival in breast cancer patients whose cancer has spread to the brain. The goal is to learn more about what influences outcomes, which may help guide future treatment decisions.
This study is testing regular MRI brain scans to find any brain metastases early in people with HER2-positive breast cancer that has spread. It aims to see if early detection can help guide treatment and improve outcomes.
This study looks at whether routine brain scans can help manage breast cancer that has spread to other parts of the body. It aims to find brain metastases early in people with certain types of high-risk breast cancer, even before symptoms appear.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.